StockData
Veru Inc. logo

Veru Inc. (VERU) stock

VERUNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026Score 6/30
$2.31+0.17 (+7.94%)

Close on Nov 18, 2026Market cap $39.39MP/E –Yield –

Veru revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Veru's revenue for the twelve months ending Sep 30, 2024 was $16.89M, up 3.6% year over year. For fiscal 2024 it was $16.89M, up 3.6% from the year before. Over ten years it grew -3.6% a year on average. The highest annual figure on record is $61.26M in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2024Sep 30, 2024$16.89M+3.6%
FY2023Sep 30, 2023$16.30M-58.6%
FY2022Sep 30, 2022$39.35M-35.8%
FY2021Sep 30, 2021$61.26M+43.8%
FY2020Sep 30, 2020$42.59M+33.9%
FY2019Sep 30, 2019$31.80M+100.5%
FY2018Sep 30, 2018$15.86M+16.2%
FY2017Sep 30, 2017$13.66M-38.3%
FY2016Sep 30, 2016$22.13M-32.1%
FY2015Sep 30, 2015$32.60M+33.1%
FY2014Sep 30, 2014$24.49M-22.1%
FY2013Sep 30, 2013$31.46M-10.2%
FY2012Sep 30, 2012$35.03M+188609.9%
FY2011Sep 30, 2011$18.57K-99.9%
FY2010Sep 30, 2010$22.22M-19.3%
FY2009Sep 30, 2009$27.54M–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2025CQ2 2025Jun 30, 2025$0-100.0%
Q2 FY2025CQ1 2025Mar 31, 2025$0-100.0%
Q4 FY2024CQ3 2024Sep 30, 2024$6.66M+72.4%
Q3 FY2024CQ2 2024Jun 30, 2024$3.95M+18.3%
Q2 FY2024CQ1 2024Mar 31, 2024$4.14M-37.2%
Q1 FY2024CQ4 2023Dec 31, 2023$2.14M-14.6%
Q4 FY2023CQ3 2023Sep 30, 2023$3.86M+49.2%
Q3 FY2023CQ2 2023Jun 30, 2023$3.34M-65.2%
Q2 FY2023CQ1 2023Mar 31, 2023$6.59M-49.4%
Q1 FY2023CQ4 2022Dec 31, 2022$2.51M-82.3%
Q4 FY2022CQ3 2022Sep 30, 2022$2.59M-83.5%
Q3 FY2022CQ2 2022Jun 30, 2022$9.60M-45.6%
Q2 FY2022CQ1 2022Mar 31, 2022$13.03M-2.3%
Q1 FY2022CQ4 2021Dec 31, 2021$14.14M-3.3%
Q4 FY2021CQ3 2021Sep 30, 2021$15.65M+33.2%
Q3 FY2021CQ2 2021Jun 30, 2021$17.66M+71.1%
Q2 FY2021CQ1 2021Mar 31, 2021$13.34M+34.2%
Q1 FY2021CQ4 2020Dec 31, 2020$14.62M+38.2%
Q4 FY2020CQ3 2020Sep 30, 2020$11.75M+34.6%
Q3 FY2020CQ2 2020Jun 30, 2020$10.32M+6.1%
Q2 FY2020CQ1 2020Mar 31, 2020$9.94M+42.5%
Q1 FY2020CQ4 2019Dec 31, 2019$10.58M+66.0%
Q4 FY2019CQ3 2019Sep 30, 2019$8.73M+67.7%
Q3 FY2019CQ2 2019Jun 30, 2019$9.73M+76.8%
Q2 FY2019CQ1 2019Mar 31, 2019$6.98M+171.1%
Q1 FY2019CQ4 2018Dec 31, 2018$6.37M+146.3%
Q4 FY2018CQ3 2018Sep 30, 2018$5.20M+40.9%
Q3 FY2018CQ2 2018Jun 30, 2018$5.50M+27.5%
Q2 FY2018CQ1 2018Mar 31, 2018$2.57M+7.0%
Q1 FY2018CQ4 2017Dec 31, 2017$2.59M-20.3%
Q4 FY2017CQ3 2017Sep 30, 2017$3.69M+3.6%
Q3 FY2017CQ2 2017Jun 30, 2017$4.31M–
Q2 FY2017CQ1 2017Mar 31, 2017$2.41M–
Q1 FY2017CQ4 2016Dec 31, 2016$3.24M–
Q4 FY2016CQ3 2016Sep 30, 2016$3.56M–

More Veru figures

See a number that looks wrong?